Categories: News

LifeKnight, Inc. Selected as Finalist for 2025 SXSW Pitch

TRAVERSE CITY, Mich., Jan. 22, 2025 /PRNewswire/ — LifeKnight, Inc., a pioneer in AI-enabled safety and health technology, has been named a finalist in the Space, Government & Security category for the 2025 SXSW Pitch. The event, presented by KPMG, showcases the most innovative global startups during the South by Southwest® (SXSW®) Conference & Festivals in Austin, TX, March 7-15, 2025.

Out of 589 applicants, LifeKnight, Inc. is one of 45 finalists across nine categories and will present on March 8, 2025. The company will showcase its AI-enabled LifeKnight Safety and Wellness Platform, which powers the LOIS Safety App, AI agents, and advanced health and safety features. This platform offers groundbreaking capabilities such as real-time emergency detection, automated response, geo-fencing for hazardous areas, and continuous health monitoring.

“Being selected as a finalist is a significant milestone,” said Avery Piantedosi, Founder and CEO of LifeKnight, Inc. “Our platform redefines safety and wellness by leveraging AI to proactively protect lives and transform emergency response.”

LifeKnight, Inc.’s innovations are supported by strategic partnerships with IBM Watson and NVIDIA, emphasizing its leadership in AI-enabled safety technology.

SXSW Pitch will culminate in an awards ceremony on March 9, where category winners and a Best in Show winner will be announced.

For more information, visit: https://www.sxsw.com/pitch

Media Contact:
Lauren Ireland
616.422.0681
389099@email4pr.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeknight-inc-selected-as-finalist-for-2025-sxsw-pitch-302356961.html

SOURCE LifeKnight, Inc.

Staff

Recent Posts

HealthTech Market Size to Reach $3,140.9 Billion by 2033 Globally, at 13.1% CAGR: Allied Market Research

The global healthtech market is experiencing rapid growth due to increasing health awareness and preventive…

2 hours ago

myTomorrows and Scout Clinical Partner to Provide Cross-Border Patient Recruitment for Clinical Trials

This innovative tech collaboration addresses emotional, logistical and financial challenges associated with international clinical trial…

2 hours ago

Astraveus Strengthens Leadership Team and Board

Jean-Paul Mangeolle joins as Chairman of the Board of DirectorsDavid Newble appointed as an Independent Board MemberLaurence…

2 hours ago

NEC Laboratories Europe and Data-Driven.AI enhance AI medical diagnosis to improve the early detection of disease and illness

HEIDELBERG, Germany, April 15, 2025 /PRNewswire/ -- NEC Laboratories Europe and Data-Driven.AI are working together to…

2 hours ago

Open nominations for the BIAL Award in Biomedicine 2025 with an increased amount to €350,000

Created to distinguish the most remarkable scientific discoveries in the biomedical field, this international award has…

2 hours ago

WELL Health Announces Results for Q4 and Full Year 2024 Reflecting Record Annual Revenue

WELL achieved annual revenue of $919.7 million in 2024, an increase of 19% compared to…

2 hours ago